Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising effects. However, the price of this innovative drug and its access have become key issues for patients and healthcare practitioners. While tirzepatide has been approved by regulatory agencies, its expensive nature presents a significant barrier to many. D